These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7267679)

  • 21. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of agreement between the salivary flow and finger-sweat print methods for the determination of the anticholinergic effects of antidepressant drugs.
    Carlini EL; Del-Porto JA; Zwicker AP
    Braz J Med Biol Res; 1985; 18(2):163-9. PubMed ID: 3913478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
    Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerance of trospium chloride in the high dose range.
    Breuel HP; Mürtz G; Bondy S; Horkulak J; Gianetti BM
    Arzneimittelforschung; 1993 Apr; 43(4):461-4. PubMed ID: 8494577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the human light reflex as a measure of the anticholinergic effects of drugs. A comparison with other measures.
    Bye CE; Clubley M; Henson T; Peck AW; Smith SA; Smith SE
    Eur J Clin Pharmacol; 1979 Feb; 15(1):21-5. PubMed ID: 421726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
    Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers.
    Kay GG; Wesnes KA
    BJU Int; 2005 Nov; 96(7):1055-62. PubMed ID: 16225528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers.
    Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM
    J Psychopharmacol; 2006 Nov; 20(6):756-70. PubMed ID: 16401653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R (-)-enantiomer.
    Schmidlin O; Gundert-Remy U; Mäurer W; Weber E
    Br J Clin Pharmacol; 1982 Dec; 14(6):799-804. PubMed ID: 7150458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ocular side-effects in peroral treatment with anticholinergic agents].
    Andersson S; Axelsson U; Sandström I
    Lakartidningen; 1979 Oct; 76(42):3645-7. PubMed ID: 393924
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticholinergic drugs: effects on oxygen consumption and energy expenditure.
    Kirvelä OA; Kanto JH; Räty HM; Iisalo E
    Anesth Analg; 1994 May; 78(5):995-9. PubMed ID: 8161002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of palmar sweating with oral phosphatidylcholine.
    Aronson PJ; Lorincz AL
    Acta Derm Venereol; 1985; 65(1):19-24. PubMed ID: 2578701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of a low-dose atropine/scopolamine mixture as a food contaminant in human volunteers.
    Perharič L; Juvan KA; Stanovnik L
    J Appl Toxicol; 2013 Sep; 33(9):980-90. PubMed ID: 22886852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of a new A.S. mouth wash 881010 as an antismoking agent: a placebo-controlled double-blind trial.
    Zmeili S; Salhab A; Shubair K; Gharaibeh M; Suliman N; Al-Kayed A; Shubair M; Abu Hijleh N; Abu Jbara M
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):41-50. PubMed ID: 10027482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.